Actualités UCB SA - UCB | Actions Euronext

Votre Hub pour des idées et discussions en direct en temps réel

UCB and Biogen Announce Positive Topline Results From Phase 3 Study of Dapirolizumab Pegol in Systemic Lupus Erythematosus and are Initiating Second Phase 3 Study in 2024

Phase 3 PHOENYCS GO study met the primary endpoint demonstrating clinical improvement in moderate-to-severe...

UCB Convening Notice to the General Meeting of the Shareholders 2024

UCB Convening Notice to the General Meeting of the Shareholders 2024 CONVENING NOTICE TO THE GENERAL MEETING OF SHAREHOLDERS The Board of...

ClearPoint Neuro and UCB Enter License Agreement for Gene Therapy Drug Delivery

SOLANA BEACH, Calif., May 24, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) a global...

UCB Convocation à L’ Assemblée Générale des Actionnaires 2023

UCB Convocation à L’ Assemblée Générale des Actionnaires 2023 CONVOCATION A L’ASSEMBLEE GENERALE DES ACTIONNAIRES Le Conseil d’Administration...

Praxis Precision Medicines and UCB Announce Epilepsy Research Collaboration

BOSTON, Dec. 13, 2022 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage...

UCB SA/NV - CONVENING NOTICE TO THE GENERAL MEETING OF SHAREHOLDERS 2022

UCB SA/NV - CONVENING NOTICE TO THE GENERAL MEETING OF SHAREHOLDERS 2022 Unofficial English translation – For convenience purposes only UCB...

UCB SA/NV - Convening notice annual shareholders meeting

UCB SA/NV - Convening notice annual shareholders meeting Unofficial English translation – For convenience purposes only UCB SA/NV - Public...

UCB SA/NV : Convening notice to the general meeting of shareholders

UCB SA/NV : Convening notice to the general meeting of shareholders Unofficial English translation – For convenience purposes only UCB...

UCB SA : Convocation à l'assemblée générale des actionnaires qui se tiendra à Bluepoint Brussels

UCB SA : Convocation à l'assemblée générale des actionnaires qui se tiendra à Bluepoint Brussels UCB - société anonymeAllée de la...

Forums

Afficher les forums

Ucb (Ucb - Bel 20)	5
UCB (Euronext Bruxelles)	7

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

UCB SA (UCB)

Votre Hub pour des idées et discussions en direct en temps réel

UCB Actualités

UCB and Biogen Announce Positive Topline Results From Phase 3 Study of Dapirolizumab Pegol in Systemic Lupus Erythematosus and are Initiating Second Phase 3 Study in 2024

UCB Convening Notice to the General Meeting of the Shareholders 2024

ClearPoint Neuro and UCB Enter License Agreement for Gene Therapy Drug Delivery

UCB Convocation à L’ Assemblée Générale des Actionnaires 2023

Praxis Precision Medicines and UCB Announce Epilepsy Research Collaboration

UCB SA/NV - CONVENING NOTICE TO THE GENERAL MEETING OF SHAREHOLDERS 2022

UCB SA/NV - Convening notice annual shareholders meeting

UCB SA/NV : Convening notice to the general meeting of shareholders

UCB SA : Convocation à l'assemblée générale des actionnaires qui se tiendra à Bluepoint Brussels

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

UCB SA (UCB) Actualités

UCB SA (UCB)

Votre Hub pour des idées et discussions en direct en temps réel

UCB Actualités

UCB and Biogen Announce Positive Topline Results From Phase 3 Study of Dapirolizumab Pegol in Systemic Lupus Erythematosus and are Initiating Second Phase 3 Study in 2024

UCB Convening Notice to the General Meeting of the Shareholders 2024

ClearPoint Neuro and UCB Enter License Agreement for Gene Therapy Drug Delivery

UCB Convocation à L’ Assemblée Générale des Actionnaires 2023

Praxis Precision Medicines and UCB Announce Epilepsy Research Collaboration

UCB SA/NV - CONVENING NOTICE TO THE GENERAL MEETING OF SHAREHOLDERS 2022

UCB SA/NV - Convening notice annual shareholders meeting

UCB SA/NV : Convening notice to the general meeting of shareholders

UCB SA : Convocation à l'assemblée générale des actionnaires qui se tiendra à Bluepoint Brussels

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application